Intelligence Ventures
4594 Lusso Ln, Jacksonville, FL, 32246, United States
Overview
We are a venture capital firm dedicated to cultivating innovation within the United States. Our commitment lies in the strategic investment and nurturing of pre-seed, seed, and Series A companies, fueling their growth and fostering the next generation of industry leaders. Our first fund, AI Health Fund I, will be focused on companies that use automation such as artificial intelligence to solve inefficiencies in biotech, pharma, medtech, and diagnostics.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 1
Sector focus
- Artificial Intelligence (AI)
- Biotechnology
- Health Care
- Life Science
- Medical Device
- Pharmaceutical
Investment portfolio
- HEARTio
Participated · Seed · Mar 2026
HEARTio’s core product, ECGio, applies deep-learning analysis to standard 12-lead electrocardiograms to predict the presence, severity and location of coronary artery blockages without invasive testing. Early validation work includes a study in the Canadian Journal of Cardiology and a larger JACC Advances study involving more than 16,000 patients that supported the model’s ability to identify coronary artery disease from routine ECGs. The company emphasizes a headless API that uses pre-deployed ECG hardware and integrates software agents to surface subtle abnormalities for clinicians. Leadership includes co-founders Utkars Jain, Adam Butchy and Michael Leasure, with John Marous as Executive Chairman and two co-Chief Commercialisation Officers. HEARTio has public goals to complete a pivotal study, obtain FDA clearance, begin generating revenue, and expand its product suite to additional cardiac indications. The founding story is partly rooted in personal loss, and the team has received recognition including Forbes 30 Under 30.
Team
Doug Nissinoff
Managing Director
LinkedIn